Since 1967, Fermilab has worked to answer these and other fundamental questions and enhance our understanding of everything we see around us. As the United States' premier particle physics laboratory, we work on the world's most advanced particle accelerators and dig down to the smallest building blocks of matter.
So, survival rate and life expectancy for stage 4 prostate cancer cannot be favorable. âº The five-year relative survival rate for prostate cancer that has spread to distant organs is 28%. This means about 28% of the patients with stage 4 prostate cancer will live for five years.
Pancreatic cancer often has poor prognosis: rates for all stages of pancreatic cancer combined are 25% 1-year survival and 6% 5-year survival. The 5-year survival rate for a localized disease is 20% while the average survival for locally advanced and metastatic disease is about 6-10 months.